Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Asia Pacific

Set Alert for Asia Pacific

As China Rushes Medical Supplies To World, Quality Issues Resurface

As China is poised to supply medical products to fight the coronavirus around the world, a battle to banish its image of poor product quality is on.

Quality Regulation Coronavirus COVID-19

Global Medtech Guidance Tracker: March 2020

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Sixty-nine guidance documents have been posted on the tracker since its last update.

International Australia

Australia Proposes ‘Carving Out’ Certain Software Products From Medtech Regs

The Australian health care products regulator is inviting feedback on proposed measures to clarify the boundary for software-based products that are captured under the regulatory framework for medical devices.

Australia Regulation

Device Makers Will Face ‘Double Supply Shock’ As Coronavirus Crisis Spreads, Experts Say

Medtech manufacturers around the globe should brace for another shock to supply chains now that the COVID-19 pandemic has shifted away from Asia, and toward North America and Europe.

Coronavirus COVID-19 Manufacturing

China’s NMPA Steps Up To The Plate In COVID-19 Fight But Much Is Left To Do

Chinese monitoring of the spread of COVID-19 locally has reported no new cases of home-grown infection in a single day for the first time since the outbreak began. It indicates control efforts, including the NMPA’s fast-tracking of relevant devices, PPE and IVDs, are having the desired effects.

China Policy

Philippines Relies On Local COVID-19 Testing Kits

The Philippines FDA says no company has applied to import and register diagnostic test kits for the novel coronavirus.

Philippines Coronavirus COVID-19

Thailand Rolls Out IMDRF-Based Risk Classifications For Devices And Diagnostics

Thailand has opted to align with IMDRF principles on the classification of devices. The change also brings the Thai FDA into line with Asean Medical Device Directive principles.

Thailand Regulation
See All

UsernamePublicRestriction

Register